Intraepithelial γδ T cells remain increased in the duodenum of AIDS patients despite antiretroviral treatment.

Intraepithelial lymphocytes (IELs) bearing the γδ T-cell receptor are a unique intestinal subset whose function remains elusive. Here, we examine how they behave in AIDS and during various regimens of antiretroviral treatment in order to obtain mechanistic insight into their adaptive or innate funct...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Dag E Nilssen, Per Brandtzaeg
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/6f71cde415f64adc95347258dc8a15ef
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6f71cde415f64adc95347258dc8a15ef
record_format dspace
spelling oai:doaj.org-article:6f71cde415f64adc95347258dc8a15ef2021-11-18T07:31:00ZIntraepithelial γδ T cells remain increased in the duodenum of AIDS patients despite antiretroviral treatment.1932-620310.1371/journal.pone.0029066https://doaj.org/article/6f71cde415f64adc95347258dc8a15ef2012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22238587/?tool=EBIhttps://doaj.org/toc/1932-6203Intraepithelial lymphocytes (IELs) bearing the γδ T-cell receptor are a unique intestinal subset whose function remains elusive. Here, we examine how they behave in AIDS and during various regimens of antiretroviral treatment in order to obtain mechanistic insight into their adaptive or innate functional in vivo properties. IELs were studied by multimarker two-colour immunofluorescence in situ staining. Consecutive duodenal biopsies were obtained from advanced infection-prone HIV(+) patients (n = 30). The systemic adaptive immune status was monitored by determining T-cell subsets and immunoglobulins in peripheral blood. The γδ IEL ratio (median 14.5%, range 1.5-56.3%) was significantly increased (p<0.02) compared with that in clinically healthy HIV(-) control subjects (n = 11, median 2.8%; range 0.3-38%), although the number of γδ IELs per mucosal length unit (U) only tended to be increased (4.0/U in HIV(+) versus 3.2/U in HIV(-) subjects). Notably, the total number of CD3(+) IELs was significantly reduced in AIDS (p<0.0001, 39.6/U in HIV(+) versus 86.4/U in HIV(-) subjects). Almost 100% of the γδ IELs were CD8(-) and they often expressed the Vδ1/Jδ1-encoded epitope (median 65.2%). HIV(+) patients on highly active antiretroviral therapy only tended to have a lower ratio of γδ IELs (median 12.8%) than those receiving no treatment (median 14.3%) or 1 nucleoside analogue (NA) (median 23.5%) or 2 NAs (median 13.0%). This minimal variation among therapy groups, contrasting the treatment response of systemic and local adaptive immunity, harmonizes with the novel idea derived from animal experiments that γδ T cells are largely innate cells in first-line microbial defence.Dag E NilssenPer BrandtzaegPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 1, p e29066 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Dag E Nilssen
Per Brandtzaeg
Intraepithelial γδ T cells remain increased in the duodenum of AIDS patients despite antiretroviral treatment.
description Intraepithelial lymphocytes (IELs) bearing the γδ T-cell receptor are a unique intestinal subset whose function remains elusive. Here, we examine how they behave in AIDS and during various regimens of antiretroviral treatment in order to obtain mechanistic insight into their adaptive or innate functional in vivo properties. IELs were studied by multimarker two-colour immunofluorescence in situ staining. Consecutive duodenal biopsies were obtained from advanced infection-prone HIV(+) patients (n = 30). The systemic adaptive immune status was monitored by determining T-cell subsets and immunoglobulins in peripheral blood. The γδ IEL ratio (median 14.5%, range 1.5-56.3%) was significantly increased (p<0.02) compared with that in clinically healthy HIV(-) control subjects (n = 11, median 2.8%; range 0.3-38%), although the number of γδ IELs per mucosal length unit (U) only tended to be increased (4.0/U in HIV(+) versus 3.2/U in HIV(-) subjects). Notably, the total number of CD3(+) IELs was significantly reduced in AIDS (p<0.0001, 39.6/U in HIV(+) versus 86.4/U in HIV(-) subjects). Almost 100% of the γδ IELs were CD8(-) and they often expressed the Vδ1/Jδ1-encoded epitope (median 65.2%). HIV(+) patients on highly active antiretroviral therapy only tended to have a lower ratio of γδ IELs (median 12.8%) than those receiving no treatment (median 14.3%) or 1 nucleoside analogue (NA) (median 23.5%) or 2 NAs (median 13.0%). This minimal variation among therapy groups, contrasting the treatment response of systemic and local adaptive immunity, harmonizes with the novel idea derived from animal experiments that γδ T cells are largely innate cells in first-line microbial defence.
format article
author Dag E Nilssen
Per Brandtzaeg
author_facet Dag E Nilssen
Per Brandtzaeg
author_sort Dag E Nilssen
title Intraepithelial γδ T cells remain increased in the duodenum of AIDS patients despite antiretroviral treatment.
title_short Intraepithelial γδ T cells remain increased in the duodenum of AIDS patients despite antiretroviral treatment.
title_full Intraepithelial γδ T cells remain increased in the duodenum of AIDS patients despite antiretroviral treatment.
title_fullStr Intraepithelial γδ T cells remain increased in the duodenum of AIDS patients despite antiretroviral treatment.
title_full_unstemmed Intraepithelial γδ T cells remain increased in the duodenum of AIDS patients despite antiretroviral treatment.
title_sort intraepithelial γδ t cells remain increased in the duodenum of aids patients despite antiretroviral treatment.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/6f71cde415f64adc95347258dc8a15ef
work_keys_str_mv AT dagenilssen intraepithelialgdtcellsremainincreasedintheduodenumofaidspatientsdespiteantiretroviraltreatment
AT perbrandtzaeg intraepithelialgdtcellsremainincreasedintheduodenumofaidspatientsdespiteantiretroviraltreatment
_version_ 1718423350262366208